DreaMed Diabetes: Funding, Investors & Team (Oct 2026)
DreaMed Diabetes is a company specializing in personalized diabetes treatment optimization solutions, established in 2014. They were the first to commercialize artificial pancreas technology and have since focused on developing decision support tools for diabetes management. DreaMed Diabetes is the only company to have FDA clearance for a decision support system using data from CGM/SMBG and insulin pumps. Their Advisor Pro software, created by diabetes professionals and powered by artificial intelligence, allows healthcare professionals to quickly analyze patient data and provide optimal treatment plans for type 1 diabetes patients. By making frequent titration changes and offering online monitoring, DreaMed Diabetes aims to improve patient treatment outcomes, lower A1C levels, and reduce the risk of complications for diabetes patients. With the use of Advisor Pro, healthcare providers can offer personalized and efficient care to patients regardless of where they are or who their caregiver is.
DreaMed Diabetes has raised $8.0M across 2 funding rounds on record, the most recent an undisclosed round of $3.0M announced in Aug 2024.
That round is below the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
DreaMed Diabetes Company Profile and Key Stats
Latest funding round on record: Aug 2024.
DreaMed Diabetes Funding Rounds
DreaMed Diabetes raised $5.0M in an undisclosed round announced in Sep 2020.
3.9 years later, an undisclosed round of $3.0M was announced in Aug 2024.
DreaMed Diabetes Founders and Leadership Team
Contact details for the DreaMed Diabetes team: 1 of 1 has an email address on file.
Start 14-day free trial →DreaMed Diabetes Funding Compared to Other Artificial Intelligence Startups
DreaMed Diabetes' latest round of $3.0M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DreaMed Diabetes in Artificial Intelligence and Petah Tiqva
Companies Similar to DreaMed Diabetes
Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform…
Platform enabling enterprises to create, test, and deploy AI agents for voice, chat, and email.
Faye provides whole-trip travel coverage and care that brings out the best in each journey with…
Arato.ai is an advanced AI agent simulation platform that helps organizations test, evaluate, and monitor…
Kinoa provides an AI-powered LiveOps platform that helps mobile app and game companies manage user…
Dream Security is a cybersecurity firm that creates artificial intelligence products to safeguard against…
Limitless Labs is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM…
SuperBuzz (TSXV: SPZ) utilizes cutting-edge GPT-3 technology, such as chatGPT, to produce targeted content…
NewCore is a security-first identity platform that governs every human and AI agent identity for the…
Odysight.AI is an AI platform that specializes in visualizing, analyzing, predictive maintenance, and…
Arito is an AI-powered finance platform that helps teams automate reporting, analyze data, and generate…
Cybord creates technologies that prevent fake, substandard, and harmful electronic parts from being…
DreaMed Diabetes Funding FAQs
What does DreaMed Diabetes do?
DreaMed Diabetes is a company specializing in personalized diabetes treatment optimization solutions, established in 2014. They were the first to commercialize artificial pancreas technology and have since focused on developing decision support tools for diabetes management. DreaMed Diabetes is the only company to have FDA clearance for a decision support system using data from CGM/SMBG and insulin pumps. Their Advisor Pro software, created by diabetes professionals and powered by artificial intelligence, allows healthcare professionals to quickly analyze patient data and provide optimal treatment plans for type 1 diabetes patients. By making frequent titration changes and offering online monitoring, DreaMed Diabetes aims to improve patient treatment outcomes, lower A1C levels, and reduce the risk of complications for diabetes patients. With the use of Advisor Pro, healthcare providers can offer personalized and efficient care to patients regardless of where they are or who their caregiver is.
How much funding has DreaMed Diabetes raised?
DreaMed Diabetes has raised $8.0M across 2 rounds on record. The most recent is an undisclosed round of $3.0M announced in Aug 2024.
When did DreaMed Diabetes last raise funding?
DreaMed Diabetes' most recent funding round on record is an undisclosed round of $3.0M, announced in Aug 2024.
Who founded DreaMed Diabetes?
FundedIQ lists Eran Atlas (Founder) at DreaMed Diabetes.
Where is DreaMed Diabetes headquartered?
DreaMed Diabetes is based in Petah Tiqva, Hamerkaz, Israel.
How many employees does DreaMed Diabetes have?
DreaMed Diabetes is in the 11-50 employee band.
How does DreaMed Diabetes' funding compare to other Artificial Intelligence startups?
DreaMed Diabetes' latest round of $3.0M is below the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,239 tracked companies over the last two years.
About FundedIQ's DreaMed Diabetes Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DreaMed Diabetes is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.